Femtobiomed Inc. (XKON:327610)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,100.00
+60.00 (2.94%)
Last updated: Dec 4, 2025, 12:15 PM KST
-61.11%
Market Cap 20.61B
Revenue (ttm) 389.96M
Net Income (ttm) -1.21B
Shares Out 8.54M
EPS (ttm) -876.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 765
Average Volume 4,783
Open 2,040.00
Previous Close 2,040.00
Day's Range 2,040.00 - 2,290.00
52-Week Range 1,294.00 - 6,390.00
Beta 0.66
RSI 64.16
Earnings Date n/a

About Femtobiomed

Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform. The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research. The company was founded in 2011 and is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 327610
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.